SOPHiA GENETICS, the shoutily and poorly capitalized named startup that’s combining machine learning tools for medical imaging and genetic sequencing to come up with a more holistic view of diseases for better patient care, has raised $110 million in new funding. The Series F round for the company was led by aMoon an Israeli healthcare and life sciences investment fund, and HItachi Ventures, the investment arm of the Hitachi Group. Financial services firms like Credit Suisse and the PIctet Group, along with previous investors including Swisscom Ventures, Endeavour Vision, Generation Investment Management, and Eurazeo Growth also participated in the financing. The company’s technology uses multiple sources of medical data to come up with potentially novel insights about how diseases spread in the body and offer better ways to coordinate care among different .